SCHEMBL5674583

SCHEMBL5674583

Cn1nc(-c2ccc(S)s2)cc1C(F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.58
▸ GAA P10253 3/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ PTGES2 Q9H7Z7 1/20 0.46
▸ POLB P06746 1/20 0.42
▸ RAB9A P51151 4/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13471700 0.84 ALDH1A1 (0.60) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL12568259 0.80 ALDH1A1 (0.56) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL14288350 0.79 ALDH1A1 (0.55) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL2569391 0.79 ALDH1A1 (0.59) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL12620551 0.79 ALDH1A1 (0.55) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL4244410 0.77 ALDH1A1 (0.53) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL1574357 0.77 ALDH1A1 (0.74) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL2058323 0.77 ALDH1A1 (0.74) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL1595309 0.76 ALDH1A1 (0.58) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL3010846 0.76 GAA (0.64) ALDH1A1GAAL3MBTL1PTGES2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1507756-A4 CCR9 INHIBITORS AND METHODS OF USE THEREOF MILLENNIUM PHARM INC (US) 2006-03-15 — — EP disclosed
EP-1507756-A1 CCR9 INHIBITORS AND METHODS OF USE THEREOF Millennium Pharmaceuticals, Inc. (US) 2005-02-23 — — EP disclosed
WO-2003099773-A1 CCR9 INHIBITORS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-12-04 — — WO disclosed
Send feedback